Harrow Health competitorsClear all

Harrow Health's top competitors include Cour Pharmaceuticals Development, Zhimeng Biopharma, CuraSen Therapeutics and Tarveda Therapeutics.
Harrow Health
Harrow Health
Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices.
Cour Pharmaceuticals Development
Cour Pharmaceuticals Development
Cour Pharmaceuticals Development is a company developing treatments and cures for immune-mediated diseases.
Zhimeng Biopharma
Zhimeng Biopharma
Zhimeng Biopharma (上海挚盟医药科技有限公司) is a biotech company developing medicines for the treatment of chronic hepatitis B (CHB) and severe neurological diseases.
CuraSen Therapeutics
CuraSen Therapeutics
CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases.
Tarveda Therapeutics
Tarveda Therapeutics
Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.
Founding Date
Founding Date
2012
Founding Date
2012
Founding Date
2017
Founding Date
2016
Founding Date
2011
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Irvine, US
Nashville, US
Roxbury Township, US
Locations
Northbrook, US HQ
Locations
HQ
Locations
San Mateo, US HQ
Locations
Watertown, US HQ
Employees
Employees
1331% decrease
Employees
284% increase
Employees
12
Employees
167% increase
Employees
333% decrease
Twitter followers
Twitter followers
492
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
41
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
340883
Alexa Website Rank
403002
Alexa Website Rank
427835
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
1
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 17k (almost 8 years ago)
Latest funding round
$ 142m (over 1 year ago)
Latest funding round
$ 54.5m (over 2 years ago)
Latest funding round
$ 30m (about 4 years ago)
Total funding raised
Total funding raised
$ 48.7m
Total funding raised
$ 17k
Total funding raised
$ 142m
Total funding raised
$ 54.5m
Total funding raised
$ 158.6m
For sources of this data, please see the company profile

View company profiles

Cour Pharmaceuticals Development
HQ
Northbrook, US
Employees
28↑ 4% increase

Cour Pharmaceuticals Development is a company developing treatments and cures for immune-mediated diseases.

View company
Zhimeng Biopharma
HQ
Employees
12

Zhimeng Biopharma (上海挚盟医药科技有限公司) is a biotech company developing medicines for the treatment of chronic hepatitis B (CHB) and severe neurological diseases.

View company
CuraSen Therapeutics
HQ
San Mateo, US
Employees
16↑ 7% increase

CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases.

View company
Tarveda Therapeutics
HQ
Watertown, US
Employees
33↓ 3% decrease

Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.

View company